News Related to Integrin Receptors

Related coverage linked through entity extraction aliases.

Nanoparticle Therapy Targets Lung Cancer and Muscle Wasting Simultaneously

Apr 07, 2026

Researchers have developed lipid nanoparticles that deliver mRNA therapeutics to simultaneously treat lung cancer and associated muscle wasting. The nanoparticles target lung tumors while preserving muscle mass, showing 2.5 times greater tumor reduction in preclinical models. This dual-action approach addresses both the primary tumor and debilitating cachexia syndrome.

Solid Biosciences Advances SGT-003 DMD Gene Therapy with FDA Alignment, Reports No Liver Toxicity

Mar 12, 2026

Solid Biosciences has secured FDA alignment on a registration pathway for its Duchenne muscular dystrophy gene therapy SGT-003, with 36 patients dosed to date showing no drug-induced liver injury, myocarditis, or other serious adverse events reported with competing therapies.